Women with a breast cancer genetic defect are less likely to develop breast cancer than previously thought, according to two studies published in the Journal of the American Medical Association. The BRCA1 and BRCA2 defects have been found to occur in a higher rate among Ashkenazi Jewish women than in the rest of the female population. Experts say that the results of the studies suggest that there should be no widespread testing of women for the BRCA genes.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
